IgG gene expression and its possible significance in prostate cancers

Prostate

Volumn 72, Issue 6, 2012, Pages 690-701

  Liu, Yuxuan ^a   Chen, Zhengshan ^b   Niu, Na ^a   Chang, Qing ^a   Deng, Ruishu ^a   Korteweg, Christine ^b   Gu, Jiang ^a,b  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

anti IgG antibody; biomarker; Gleason score; immunoglobulin G; prostate cancer

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN KAPPA CHAIN; LIPOCORTIN 5; PROPIDIUM IODIDE;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER PROGNOSIS; CELL ASSAY; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; GENE EXPRESSION; GLEASON SCORE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOGLOBULIN GENE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; IN VITRO STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAINING; TISSUE MICROARRAY; WESTERN BLOTTING;

ADENOCARCINOMA; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOGLOBULIN G; MALE; NEOPLASM GRADING; PROSTATE; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS;

EID: 84858746880     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.21476     Document Type: Article

References (39)

1. Jemal A, Siegel R, Xu J, Ward E,. Cancer statistics. CA Cancer J Clin 2010; 60 (5): 277-300.
2. Bailar JC III, Mellinger GT, Gleason DF,. Survival rates of patients with prostatic cancer, tumor stage, and differentiation-Preliminary report. Cancer Chemother Rep 1966; 50 (3): 129-136.
3. Gleason DF, Mellinger GT,. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol 1974; 111 (1): 58-64.
4. Gleason DF,. Histologic grading of prostate cancer: A perspective. Hum Pathol 1992; 23 (3): 273-279.
5. Ohori M, Wheeler TM, Scardino PT,. The New American Joint Committee on Cancer and International Union Against Cancer TNM classification of prostate cancer. Clinicopathologic correlations. Cancer 1994; 74 (1): 104-114. (Pubitemid 24187618)
6. Nelson WG, De Marzo AM, Isaacs WB,. Prostate cancer. N Engl J Med 2003; 349 (4): 366-381. (Pubitemid 36886244)
7. De Marzo AM, Platz EA, Sutcliffe S, Xu J, Gronberg H, Drake CG, Nakai Y, Isaacs WB, Nelson WG,. Inflammation in prostate carcinogenesis. Nat Rev Cancer 2007; 7 (4): 256-269. (Pubitemid 46486616)
8. Qiu X, Zhu X, Zhang L, Mao Y, Zhang J, Hao P, Li G, Lv P, Li Z, Sun X, Wu L, Zheng J, Deng Y, Hou C, Tang P, Zhang S, Zhang Y,. Human epithelial cancers secrete immunoglobulin G with unidentified specificity to promote growth and survival of tumor cells. Cancer Res 2003; 63 (19): 6488-6495. (Pubitemid 37255201)
9. Babbage G, Ottensmeier CH, Blaydes J, Stevenson FK, Sahota SS,. Immunoglobulin heavy chain locus events and expression of activation-induced cytidine deaminase in epithelial breast cancer cell lines. Cancer Res 2006; 66 (8): 3996-4000.
10. Yang SB, Chen X, Wu BY, Wang MW, Cai CH, Cho DB, Chong J, Li P, Tang SG, Yang PC,. Immunoglobulin kappa and immunoglobulin lambda are required for expression of the anti-apoptotic molecule Bcl-xL in human colorectal cancer tissue. Scand J Gastroenterol 2009; 44 (12): 1443-1451.
11. Lee G, Ge B,. Cancer cell expressions of immunoglobulin heavy chains with unique carbohydrate-associated biomarker. Cancer Biomark 2009; 5 (4): 177-188.
12. Zheng J, Huang J, Mao Y, Liu S, Sun X, Zhu X, Ma T, Zhang L, Ji J, Zhang Y, Yin CC, Qiu X,. Immunoglobulin gene transcripts have distinct VHDJH recombination characteristics in human epithelial cancer cells. J Biol Chem 2009; 284 (20): 13610-13619.
13. Hu D, Zheng H, Liu H, Li M, Ren W, Liao W, Duan Z, Li L, Cao Y,. Immunoglobulin expression and its biological significance in cancer cells. Cell Mol Immunol 2008; 5 (5): 319-324.
14. Zheng H, Li M, Ren W, Zeng L, Liu HD, Hu D, Deng X, Tang M, Shi Y, Gong J, Cao Y,. Expression and secretion of immunoglobulin alpha heavy chain with diverse VDJ recombinations by human epithelial cancer cells. Mol Immunol 2007; 44 (9): 2221-2227. (Pubitemid 46097112)
15. Chen Z, Gu J,. Immunoglobulin G expression in carcinomas and cancer cell lines. FASEB J 2007; 21 (11): 2931-2938. (Pubitemid 47372759)
16. Chen Z, Huang X, Ye J, Pan P, Cao Q, Yang B, Li Z, Su M, Huang C, Gu J,. Immunoglobulin G is present in a wide variety of soft tissue tumors and correlates well with proliferation markers and tumor grades. Cancer 116 (8): 1953-1963.
17. Niu N, Zhang J, Sun Y, Wang S, Korteweg C, Gao W, Gu J,. Expression and distribution of immunoglobulin G and its receptors in an immune privileged site: The eye. Cell Mol Life Sci 68 (14): 2481-2492.
18. Niu N, Zhang J, Guo Y, Zhao Y, Korteweg C, Gu J,. Expression and distribution of immunoglobulin G and its receptors in the human nervous system. Int J Biochem Cell Biol 43 (4): 556-563.
19. Ablin RJ, Gonder MJ, Soanes WA,. Localization of immunoglobulins in human prostatic tissue. J Immunol 1971; 107 (2): 603-604.
20. Gahankari DR, Golhar KB,. An evaluation of serum and tissue bound immunoglobulins in prostatic diseases. J Postgrad Med 1993; 39 (2): 63-67.
21. van Sande M, van Camp K,. Immunoglobulins in tissues of human benign prostatic hypertrophy. Urol Res 1983; 11 (4): 171-172. (Pubitemid 14231009)
22. Sasaki T, Ryo A, Uemura H, Ishiguro H, Inayama Y, Yamanaka S, Kubota Y, Nagashima Y, Harada M, Aoki I,. An immunohistochemical scoring system of prolyl isomerase Pin1 for predicting relapse of prostate carcinoma after radical prostatectomy. Pathol Res Pract 2006; 202 (5): 357-364.
23. Lynch S, Kelleher D, McManus R, O'Farrelly C,. RAG1 and RAG2 expression in human intestinal epithelium: Evidence of extrathymic T cell differentiation. Eur J Immunol 1995; 25 (5): 1143-1147.
24. del Vecchio MT, Tripodi SA, Arcuri F, Pergola L, Hako L, Vatti R, Cintorino M,. Macrophage migration inhibitory factor in prostatic adenocarcinoma: Correlation with tumor grading and combination endocrine treatment-related changes. Prostate 2000; 45 (1): 51-57.
25. Zheng H, Li M, Liu H, Ren W, Hu DS, Shi Y, Tang M, Cao Y,. Immunoglobulin alpha heavy chain derived from human epithelial cancer cells promotes the access of S phase and growth of cancer cells. Cell Biol Int 2007; 31 (1): 82-87. (Pubitemid 46138048)
26. Egevad L, Granfors T, Karlberg L, Bergh A, Stattin P,. Prognostic value of the Gleason score in prostate cancer. BJU Int 2002; 89 (6): 538-542. (Pubitemid 34948295)
27. Gatenby RA, Gawlinski ET,. A reaction-diffusion model of cancer invasion. Cancer Res 1996; 56 (24): 5745-5753. (Pubitemid 26422183)
28. Gatenby RA, Gawlinski ET,. The glycolytic phenotype in carcinogenesis and tumor invasion: Insights through mathematical models. Cancer Res 2003; 63 (14): 3847-3854. (Pubitemid 36917892)
29. Gursel EO, Megalli MR, Veenema RJ,. Serum immunoglobulins in patients with prostate cancer. Urol Res 1973; 1 (4): 145-148.
30. Romics I, Feher J, Horvath J,. Immunological studies of patients with tumours of the prostate and bladder (a retrospective analysis). Int Urol Nephrol 1983; 15 (4): 339-345.
31. Miller JC, Zhou H, Kwekel J, Cavallo R, Burke J, Butler EB, Teh BS, Haab BB,. Antibody microarray profiling of human prostate cancer sera: Antibody screening and identification of potential biomarkers. Proteomics 2003; 3 (1): 56-63. (Pubitemid 36151068)
32. Abdul M, Hoosein NM,. Gammopathy associated with advanced prostate carcinoma. Urol Res 1995; 23 (3): 185-188.
33. Kanoh Y, Ohara T, Tadano T, Kanoh M, Akahoshi T,. Changes to N-linked oligosaccharide chains of human serum immunoglobulin G and matrix metalloproteinase-2 with cancer progression. Anticancer Res 2008; 28 (2A): 715-720. (Pubitemid 351578913)
34. Kanoh Y, Egawa S, Baba S, Akahoshi T,. Associations of IgG N-linked oligosaccharide chains and proteases in sera of prostate cancer patients with and without alpha2-macroglobulin deficiency. J Clin Lab Anal 2009; 23 (2): 125-131.
35. Kanoh Y, Ohara T, Egawa S, Baba S, Akahoshi T,. Prognostic potential of a PSA complex in sera of prostate cancer patients with alpha2-macroglobulin deficiency. J Clin Lab Anal 2008; 22 (4): 302-306.
36. Kamada M, Liang Z, Koide SS,. Identification of IgG and Fc-binding proteins in human seminal plasma and sperm. Arch Androl 1991; 27 (1): 1-7.
37. Thaler CJ, Faulk WP, McIntyre JA,. Soluble antigens of IgG receptor Fc gamma RIII in human seminal plasma. J Immunol 1989; 143 (6): 1937-1942. (Pubitemid 19241210)
38. Maeda N, Kamada M, Daitoh T, Maegawa M, Hirano K, Aono T, Shiotsu T, Kanayama H, Kagawa S, Futaki S, Muraguchi M, Ohmoto Y, Liang Z, Koide S,. Immunoglobulin binding factor: A new tumor marker for prostatic tumors. Prostate 1994; 24 (3): 125-130. (Pubitemid 24109592)
39. Maegawa M, Kamada M, Maeda N, Aono T, Izumi K, Kagawa S, Koide SS,. Colocalization of immunoglobulin binding factor and prostate specific antigen in human prostate gland. Arch Androl 1996; 37 (3): 149-154. (Pubitemid 26397955)